 | AfferentProvidence, RI
Afferent Corporation is pioneering a new class of medical devices to treat chronic neurological dysfunction. Its lead technology enhances the function of mechanoreceptor cells involved in sensory perception as a means of restoring brain function following stroke, addressing complications resulting from diabetic neuropathy, and improving elderly balance. Co-investors include New Science Ventures and NITTA Corporation. |
 | GetWellNetworkBethesda, MD
GetWellNetwork, Inc. is a leading provider of Interactive Patient Care (IPC) solutions. In partnership with thought leading hospitals and healthcare systems, the company delivers innovative software, hardware, and related services to help transform healthcare organization into IPC environments to drive optimal patient outcomes. Co-investors are Valhalla Partners and Grosvenor Fund.
|
 | MedOptionsOld Saybrook, CT
MedOptions is the leading provider of behavioral health and primary medical care services to long term care and assisted living facilities in Southern New England. Co-invest with Housatonic Partners. |
 | Novare SurgicalCupertino, CA
Novare is the developer of Endolink, a family of articulating hand-held minimally invasive instruments designed to mirror the surgeon’s hand direction and wrist movements with full range of motion. Co-investors are Tudor Investment Corporation, Canaan Partners, Three Arch Partners, and Channel Medical Partners. |
 | Spirus MedicalStoughton, MA
Spirus Medical has developed a revolutionary new medical device for use in the endoscopic diagnosis and treatment of gastrointestinal (GI) disorders. Spirus's endoluminal technology has applications in other medical disciplines including urology and gynecology. Co-investors include BioVentures Investors. |
 | SwissrayElizabeth, NJ
Swissray is the industry pioneer in the design and manufacture of direct digital radiography (x-ray) systems, which dramatically improves overall productivity and significantly lowers the cost of general radiography in comparison to conventional or computed radiography. Co-investors include IVP, 3i, and Commonwealth Capital. |
